• Français
  • Search
  • Conference
    • Welcome to CAHR 2020: Quebec City, Quebec
    • Sponsors & Exhibitors
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2014- 2019
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • Welcome to CAHR 2020: Quebec City, Quebec
    • Sponsors & Exhibitors
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Clinical Summaries
    • UWW E-Learning Modules
    • Scientific Poster Module
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2014- 2019
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers

Peter Quashie

Having spent his school years in Botswana, Peter Quashie was familiar with the toll AIDS was taking in the community around him. By high school, the Ghana native had already decided that if he had the opportunity, he would be a researcher and seek a cure for HIV/AIDS.

“That was the only thing that I wanted to do,” he says.

Flash forward to 2012, and Quashie is fulfilling his dream, carrying out his doctoral research in the McGill University lab of Dr. Mark Wainberg, one of the world’s pre-eminent HIV researchers, with the support of a CAHR Doctoral Research Award. (He chose Dr. Wainberg’s lab based on his research interest, incidentally, not even knowing what a fundamental figure the Canadian researcher is – “I didn’t know how big he was,” Quashie says.)

Quashie’s research focuses on drug resistance to HIV treatment. One of the main ways drugs act to prevent the progression of HIV is by interfering with the insertion of the HIV genome into the host genome, using a class of drugs called integrase inhibitors. HIV, ever wily, has figured out how to bypass the first-generation HIV integrase inhibitors, becoming resistant to their action, so Quashie is focusing his efforts on the second-generation drugs. His hypothesis is that the second-generation drugs inhibit HIV integration in a different way. He is trying to find mutations in HIV that make it resistant to these second-generation drugs, in the hope that it might, one day, lead to the development of even more effective treatments for HIV.

For Quashie, that is one of the benefits of working in Dr. Wainberg’s lab – he has freedom in choosing his research topic, but Dr. Wainberg keeps everyone’s focus strictly on the clinic.

“It’s lab-based work, but it’s also viable in the clinical setting,” says Quashie of his research. “As we formulate our hypothesis, we’re always thinking about the clinical aspects.”

“Our research revolves very strongly around HIV drug resistance and obviously that’s a clinically relevant area,” says Dr. Wainberg. “Peter is very much in the thick of this. He’s a great student and does excellent work.”

Having a CAHR Doctoral Research Award has played a major role in Quashie’s success to date. It’s enabled him to focus on his research, rather than being a teaching assistant, and it’s enabled him to attend conferences such as the Fourth International Conference on Retroviral Integration, held in Italy in fall 2011. It’s also enabled him to collaborate with his colleagues in the Wainberg lab, helping Quashie to build the elements of a research career, such as publications and other measures of research impact.

While he’s focused on drug resistance right now, Quashie’s ultimate goal remains to find a cure for HIV/AIDS, and that’s where he plans on spending his time once finished his PhD. And, despite the obstacles standing in the way of a cure, Quashie believes that one will be found – or even more likely, a multitude of cures that work in different ways.

“I wouldn’t say no [to the possibility of a cure],” he says. “But I would not be able to put a time frame on that.”

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs

The 29th annual Canadian Conference on HIV/AIDS Research will be held April 30-May 3 in Quebec City, QC

Learn More

Recent News

  • Vous connaissez une personne d’exception qui a élargi nos connaissances du traitement et de la prévention du VIH et relevé la qualité de vie de ceux et celles vivant avec la maladie? Présentez sa candidature au Prix Ruban Rouge! Rouge! #A bit.ly/prixrubanrouge…
  • Do you know an outstanding individual that has increased our understanding of the treatment and prevention of HIV/AIDS, while enhancing the quality of life of those living with this disease? Nominate them for our #CAHR2020 Red Ribbon Award! bit.ly/cahrredribbona…
  • Soyez candidat(e) à un des Prix d’excellence en recherche ACRV-CANFAR 2020 soulignant l’apport des chercheurs canadiens à la recherche sur le VIH/sida au Canada et à l’étranger. bit.ly/prixexcellence… fIYQVQG
  • Apply for the 2020 CAHR-CANFAR Excellence in Research Awards, which recognizes the contributions of Canadian researchers in HIV/AIDS research in Canada and internationally. bit.ly/excellenceinre… @CANFAR
  • Il ne reste que trois jours pour demander une bourse de voyage pour la CROI. #CROI2020 Faites vite! bit.ly/CAHR-Awardsfr
  • Journée mondiale du SIDA 2019
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

236 Metcalfe Street, Suite 302
Ottawa, Ontario K2P 1R3

613-747-2465
info@cahr-acrv.ca
  • Media
  • Contact
  • Français
© 2019 Canadian Association for HIV Research. All Rights Reserved. Code+Design by

Copyright © 2019 · CAHR 2017 on Genesis Framework · WordPress · Log in